FDA Approves Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors
The FDA has approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) for subcutaneous injection across approved adult solid tumor nivolumab (Opdivo) indications.
The FDA has approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) for subcutaneous injection across approved adult solid tumor nivolumab (Opdivo) indications.
Dharini Bhammar, PhD, MBBS, is a respiratory physiologist and evidence enthusiast.
Our expert operational investment team drives vision and success through vast experience in the multi-sector recruitment mergers and acquisitions market. We are a small yet…
A hematology fellow discusses findings from 2 surveys he coauthored, which sought to identify gaps in community practice training during hematology/oncology fellowship.
Neglected tropical diseases (NTDs) represent a group of chronic and debilitating infections that affect more than one billion people, predominantly in low-income communities with limited…
Abstract. Biomarkers of ageing serve as important outcome measures in longevity-promoting interventions. However, there is limited consensus on which speci
A lot has already been written about a new scientific paper, “Excess mortality across countries in the Western World since the COVID-19…
Click on the article title to read more.
Department of Haemato-Oncology, Comprehensive Cancer Centre, King’s College London, London, UK Department of Haemato-Oncology, Comprehensive Cancer Centre, King’s College London, London, UK Department of Haemato-Oncology,…
The history of spying shows that many agencies have experimented with using animals for undercover work to gather information.